Tradeoffs

How Gov. Gavin Newsom’s ambitious plan to force more people into treatment left many families still searching for help.Guest(s):June DudasMarisa Kendall, homelessness reporter, CalMattersRead CalMatters full “Courting Disappointment” series here. Learn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift.

Maryland finds out how much the state will get from a nationwide competition for federal rural health investment.Guest(s):Christina Koontz, paramedic Elizabeth Kromm, assistant secretary for population health and strategic initiatives, Maryland Department of HealthMike Salvadge, chief of emergency medical services, Allegany County, Md. Meena Seshamani, Maryland secretary of healthHemi Tewarson, executive director, National Academy for State Health PolicyLearn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift.

We follow Maryland's 52-day rush to convince the Trump administration to give the state new funding to transform rural health care.Guests:Bonita Baer, Maryland residentMark Boucot, president and CEO of Garrett Regional Medical Center and Potomac Valley Hospital Elizabeth Kromm, assistant secretary for population health and strategic initiatives, Maryland Department of HealthLevi Lantz, ALL Produce & GreenhouseKen Ulman, former executive, Howard County, Maryland; president of Margrave StrategiesLearn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift.

Many potent new medicines pose a host of challenges for drug companies trying to copy and sell similar versions on the cheap. Can those companies find a sustainable path forward, or will patients get left stuck paying exorbitant prices?Guests:Christine Baeder, MBA, President, Apotex USAAlfred Engelberg, JD, retired attorney and former counsel to the Generic Pharmaceutical Industry AssociationJeremy Greene, MD, PhD, Professor of Medicine and the History of Medicine, Johns Hopkins UniversityCandy Meyer, PatientBhaven Sampat, PhD, Professor, Arizona State University School for the Future of Innovation in SocietyMarta Wosińska, PhD, Senior Fellow, Brookings InstitutionLeslie Walker, Senior Reporter/Producer, TradeoffsLearn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift.

Rural health experts dig into the Trump administration’s effort to transform rural health care.Guests:Kevin Bennett, Director Center for Rural & Primary Healthcare; Professor, Family and Preventative Medicine, School of Medicine Columbia, University of South CarolinaPaula Chatterjee, Director of Health Equity Research, Penn LDI; Assistant Professor, Medicine, Perelman School of MedicineSarah Jane Tribble, Chief Rural Correspondent, KFF Health NewsRachel Werner, Executive Director, Leonard Davis Institute of Health Economics; Professor of Medicine, Perelman School of Medicine, University of PennsylvaniaLearn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift.

America pays less, on average, than any other major country for our generic drugs. But selling essential drugs at such low prices comes with hidden costs — from quality problems to frequent shortages.This is the second episode of Race to the Bottom, a three-part series by Tradeoffs on the problems plaguing the generic drugs we all rely on — and how we could fix them.Guests:Christine Baeder, MBA, President, Apotex USALaura Bray, MBA, Founder, Angels for ChangeCraig Burton, Senior Vice President of Policy and Strategic Alliances, Association for Accessible MedicinesIilun Murphy, MD, Director of the Office of Generic Drugs, FDALeslie Walker, Senior Reporter/Producer, TradeoffsMarta Wosińska, PhD, Senior Fellow, Brookings InstitutionLearn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift.